Craneware (LON:CRW) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened

Key Points

• Craneware shares crossed above their 200-day moving average, trading at GBX 2,360 ($31.74), well above the average of GBX 1,970.94 ($26.51).
• Analysts from Berenberg Bank and Shore Capital have set new price targets, with Berenberg targeting GBX 2,800 ($37.66) and Shore Capital at GBX 2,650 ($35.64), both maintaining a "buy" rating.
• The company has a market cap of £1.01 billion and a high P/E ratio of 87.19, indicating significant growth expectations from investors.

Craneware plc (LON:CRW - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,970.94 ($26.61) and traded as high as GBX 2,450 ($33.08). Craneware shares last traded at GBX 2,360 ($31.86), with a volume of 18,044 shares.

Analysts Set New Price Targets

Several analysts recently commented on CRW shares. Shore Capital reaffirmed a "buy" rating and set a GBX 2,650 ($35.78) target price on shares of Craneware in a report on Wednesday, July 16th. Berenberg Bank began coverage on shares of Craneware in a research note on Wednesday, July 16th. They issued a "buy" rating and a GBX 2,800 ($37.80) price target on the stock.

Craneware Trading Down 1.8%

The business's 50-day simple moving average is GBX 2,218.68 and its two-hundred day simple moving average is GBX 1,974.22. The firm has a market capitalization of £949.56 million, a price-to-earnings ratio of 81.65 and a beta of 0.28. The company has a quick ratio of 1.00, a current ratio of 0.63 and a debt-to-equity ratio of 12.22.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.